Latest TWi Pharmaceuticals Inc. Stories

2014-04-23 08:30:49

TAIPEI, April 23, 2014 /PRNewswire/ -- TWi Pharmaceuticals, Inc. today announced that it has entered into a settlement agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. to settle all outstanding patent litigation related to TWi's lidocaine topical patch 5% product. An Abbreviated New Drug Application (ANDA) for TWi's product is currently under review at the U.S. Food and Drug Administration (FDA). If approved, TWi's product would be a...

2014-04-07 08:29:00

TAIPEI, April 7, 2014 /PRNewswire/ -- TWi Pharmaceuticals, Inc., today announces the ANDA approval of the generic equivalent to Procardia XL® (Nifedipine) Extended Release Tablets, 30 mg, 60 mg and 90 mg, in the United States. TWi has begun the launch preparation with its US distributor partner and will begin marketing the product as soon as the launch preparation is completed. Procardia XL® 30 mg, 60 mg and 90 mg, Extended Release Tablets marketed by Pfizer Inc and the generic...

Word of the Day
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'